tirzepatide gip analog Explained: The Dual / GLP-1 Agonist (UK 2026) Insights into the Mechanism of

Long-term safety beyond 5 years is still under study

Timing your injection on a consistent day each week and pairing the protocol with adequate protein intake (80 to 100g daily), proper hydration (64 to 80 ounces of water), and small frequent meals dramatically improves both results and tolerability

Bigger jumps almost always mean rougher side effects

Dual agonist (Tirzepatide): Mentioned earlier, tirzepatide (Lilly) is a single peptide that activates both the GLP-1 and GIP (Glucose-dependent Insulinotropic Polypeptide) receptors

"More than half of those who stopped restarted therapy within a year (41.5%), and nearly two-thirds did so within two years (58%)," Sontha said

Its ability to promote weight loss is also a major benefit, as excess weight is a key driver of insulin resistance